COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 11: Articles 101-110  | Next

Shedding of mitochondrial Voltage-Dependent Anion Channel-1 (VDAC1) Reflects COVID-19 Severity and Reveals Macrophage Dysfunction
Sjogren, M., Duner, P., De Marinis, Y., Neumann, A., Leandersson, K., Rasmussen, M., Wollheim, C. B., Salehi, A.
10.1101/2025.07.07.663218 — Posted: 2025-07-08
Respiratory syncytial virus infection confers heterologous protection against SARS-CoV-2 via induction of γδ T cell-mediated trained immunity and SARS-CoV-2 reactive mucosal T cells
Adam, A., Wu, W., Jones, M. C., Hao, H., FNU, A., Samir, P., Bao, X., Wang, T.
10.1101/2025.07.02.662833 — Posted: 2025-07-07
Human pluripotent stem cell-derived bronchial airway organoids provide insights into differential innate immune and long-term responses to SARS-CoV-2 infection in healthy and COPD.
Morichon, L., SWAIN, J., Gros, N., Nasri, A., Foisset, F., Galisot, G., Racine, V., ASSOU, S., Bourdin, A., de Vos, J., MURIAUX, D.
10.1101/2025.06.30.662440 — Posted: 2025-07-02
The impact of clade B lineage 5 MERS coronaviruses spike mutations from 2015 to 2023 on virus entry and replication competence
So, R. T., Lau, K. K., Zhou, Z., Poon, L. L., Peiris, M.
10.1101/2025.06.30.662263 — Posted: 2025-07-01
Exploring Dynamic Modulation of Binding, Allostery and Immune Resistance in the SARS-CoV-2 Spike Complexes with Classes of Antibodies Targeting Cryptic Binding Sites: Antibody-Specific Augmentations of Conserved Allosteric Architecture Can Influence Evolution of Viral Escape
Alshahrani, M., Parikh, V., Foley, B., Verkhivker, G.
10.1101/2025.06.28.662162 — Posted: 2025-07-01
SARS-CoV-2 spike protein amyloid fibrils impair fibrin formation and fibrinolysis
Westman, H., Hammarström, P., Nyström, S.
10.1101/2025.06.30.661938 — Posted: 2025-07-01
Back-projection improves inference from sparsely sampled genomic surveillance data
Finney, E. E., Lee, B., Ahmed, S. F., Sohail, M. S., Quadeer, A. A., McKay, M. R., Barton, J. P.
10.1101/2025.06.29.662219 — Posted: 2025-07-01
Engineering Versatile Two-Dimensional Nanobody-Origami Architectures for Enhanced Antiviral Activity
Song, T., Achi, J. G., Anirudhan, V., Le, L. T. P., Morshed, M., Wang, X., Rong, L., Wang, X.
10.1101/2025.06.27.662057 — Posted: 2025-06-30
SARS-CoV-2 Viral Pseudoparticles Preferentially Infect Ectoderm In Human Embryonic Tissues
Song, A., Talbot, P.
10.1101/2025.06.27.662024 — Posted: 2025-06-30
SARS-CoV-2 infection disrupts syncytial and endothelial integrity and alters PLGF levels in the placenta
Jones, B. R., Nobrega, G. M., Kumar, D., Diveley, E., Antolini-Tavares, A., Souza, R. T., Cecatti, J. G., Kelly, J. C., Costa, M. L., Mysorekar, I. U.
10.1101/2025.06.27.661568 — Posted: 2025-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).